Search Results - "Ahya, V"

Treatment of PTLD with Rituximab or Chemotherapy by Elstrom, R.L., Andreadis, C., Aqui, N.A., Ahya, V.N., Bloom, R.D., Brozena, S.C., Olthoff, K.M., Schuster, S.J., Nasta, S.D., Stadtmauer, E.A., Tsai, D.E.

“…Information regarding treatment of post‐transplant lymphoproliferative disease (PTLD) beyond reduction in immunosuppression (RI) is limited. We retrospectively…”
Get full text

EBV PCR in the Diagnosis and Monitoring of Posttransplant Lymphoproliferative Disorder: Results of a Two‐Arm Prospective Trial by Tsai, D. E., Douglas, L., Andreadis, C., Vogl, D. T., Arnoldi, S., Kotloff, R., Svoboda, J., Bloom, R. D., Olthoff, K. M., Brozena, S. C., Schuster, S. J., Stadtmauer, E. A., Robertson, E. S., Wasik, M. A., Ahya, V. N.

“…While EBV PCR is used in the management of PTLD, the optimal primer set, relative importance of intracellular versus free plasma EBV, and the baseline profile…”
Get full text

Deep Vein Thrombosis in Extracorporeal Membrane Oxygenation Bridged Lung Transplant Recipients by Shtraichman, O., Courtwright, A., Diamond, J.M., Ahya, V., Christie, J.D., Hadjiliadis, D., Lee, J.C., Patel, N.B., Berg, A., Cantu, E., Crespo, M.M., Bermudez, C.A.

“…Rates of deep vein thrombosis (DVT) range from 20-60% in patients undergoing extracorporeal membrane oxygenation (ECMO) for acute respiratory distress…”
Get full text

Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post‐Lung Transplantation by Hoffman, S. A., Wang, L., Shah, C. V., Ahya, V. N., Pochettino, A., Olthoff, K., Shaked, A., Wille, K., Lama, V. N., Milstone, A., Ware, L. B., Orens, J., Weinacker, A., Demissie, E., Bellamy, S., Kawut, S. M., Hancock, W. W., Christie, J. D.

“…Primary graft dysfunction (PGD) after lung transplantation causes significant morbidity and mortality. We aimed to determine the role of cytokines and…”
Get full text

A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Study of Rabbit ATG in the Prophylaxis of Acute Rejection in Lung Transplantation by Snell, G. I., Westall, G. P., Levvey, B. J., Jaksch, P., Keshavjee, S., Hoopes, C. W., Ahya, V., Mehta, A., Trulock, E. P.

“…ATG‐Fresenius S (ATG‐F) is a polyclonal anti‐human‐T‐lymphocyte immunoglobulin preparation that has been clinically developed to prevent episodes of acute…”
Get full text

Mycobacterium Abscessus in Lung Transplant Recipients: The University of Pennsylvania Experience by Pena, T, Frye, L, Ahya, V, Diamond, J, Hadjiliadis, D, Christie, J, Shah, R

Get full text

Elevated Plasma Clara Cell Secretory Protein Concentration Is Associated with High‐Grade Primary Graft Dysfunction by Diamond, J. M., Kawut, S. M., Lederer, D. J., Ahya, V. N., Kohl, B., Sonett, J., Palmer, S. M., Crespo, M., Wille, K., Lama, V. N., Shah, P. D., Orens, J., Bhorade, S., Weinacker, A., Demissie, E., Bellamy, S., Christie, J. D., Ware, L. B.

“…Primary graft dysfunction (PGD) is the leading cause of early posttransplant morbidity and mortality after lung transplantation. Clara cell secretory protein…”
Get full text

Medical complications of lung transplantation by Kotloff, R.M, Ahya, V.N

“…Surgical advances, in conjunction with more effective immunosuppressive strategies, have propelled the field of lung transplantation forward and have made…”
Get full text

Elevated Plasma Long Pentraxin‐3 Levels and Primary Graft Dysfunction After Lung Transplantation for Idiopathic Pulmonary Fibrosis by Diamond, J. M., Lederer, D. J., Kawut, S. M., Lee, J., Ahya, V. N., Bellamy, S., Palmer, S. M., Lama, V. N., Bhorade, S., Crespo, M., Demissie, E., Sonett, J., Wille, K., Orens, J., Shah, P. D., Weinacker, A., Weill, D., Kohl, B. A., Deutschman, C. C., Arcasoy, S., Shah, A. S., Belperio, J. A., Wilkes, D., Reynolds, J. M., Ware, L. B., Christie, J. D.

“…Primary graft dysfunction (PGD) after lung transplantation may result from ischemia reperfusion injury (IRI). The innate immune response to IRI may be mediated…”
Get full text

Lung Transplant Experience with Public Health Services Increased Risk Donors: Recipient Outcomes and Incidence of Transmission and Conversion by Bermudez, C.A, Molina, M.R, Thomasson, A.M, Blumberg, E, Lee, J, Gardo, L, Ahya, V, Blumenthal, N, Cantu, E, Christie, J.D, Courtwright, A, Diamond, J, Golato, J, Hadjiliadis, D, Hobson, E.J, Patel, N, Porteous, M, Crespo, M

Get full text

Causes and Preventability of Unplanned Rehospitalization Following Lung Transplantation by Courtwright, A, Zaleski, D, Ahya, V, Bermudez, C, Blumenthal, N, Cantu, E, Christie, J, Claridge, T, Crespo, M, Golato, J, Hadjiliadis, D, Hobson, E, Lee, J, Molina, M, Patel, N, Porteous, M, Diamond, J

Get full text

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Study of Rabbit ATG in the Prophylaxis of Acute Rejection in Lung Transplantation by Snell, G.I, Westall, G.P, Levvey, B.J, Jaksch, P, Keshavjee, S, Hoopes, C.W, Ahya, V, Mehta, A, Trulock, E.P

Get full text

Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation by HOFLMAN, S. A, WANG, L, WARE, L. B, ORENS, J, WEINACKER, A, DEMISSIE, E, BELLAMY, S, KAWUT, S. M, HANCOCK, W. W, CHRISTIE, J. D, SHAH, C. V, AHYA, V. N, POCHETTINO, A, OLTHOFL, K, SHAKED, A, WILLE, K, LAMA, V. N, MILSTONE, A

Get full text

Association of Clinical Risk Factors with Functional Status Following Lung Transplantation by Sager, J. S., Kotloff, R. M., Ahya, V. N., Hadjiliadis, D., Simcox, R., Blumenthal, N. P., Mendez, J., Bilker, W. B., Pochettino, A., Christie, J. D.

“…A fundamental goal of lung transplantation is the regaining of functional capacity, yet little is known about what factors are associated with the achievement…”
Get full text

209 Functional TLR4 Polymorphisms Are Associated with Lower Risk of Primary Graft Dysfunction (PGD) after Lung Transplantation by Diamond, J.M, Feng, R, Meyer, N.J, Shah, R, Kawut, S.M, Lederer, D.J, Lee, J.C, Ahya, V, Cantu, E, Weinacker, A, Bhorade, S, Lama, V.N, Orens, J.B, Sonett, J, Wille, K.M, Crespo, M, Weill, D, Kohl, B, Arcasoy, S.M, Shah, A.S, Shah, P.D, Demissie, E, Reynolds, J.M, Belperio, J.A, Wilkes, D, Ware, L.B, Palmer, S.M, Christie, J.D

Get full text

A prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction by Barton, T.D., Blumberg, E.A., Doyle, A., Ahya, V.N., Ferrenberg, J.M., Brozena, S.C., Limaye, A.P.

“…: Background: Polyomavirus (primarily BK virus [BKV]) infection is an important cause of chronic renal dysfunction in renal transplant recipients, but its…”
Get full text

47 PTX3 Polymorphisms Are Associated with Primary Graft Dysfunction after Lung Transplantation by Diamond, J.M, Feng, R, Meyer, N, Lederer, D, Lee, J, Kawut, S, Ahya, V, Cantu, E, Palmer, S, Weinacker, A, Bhorade, S, Lama, V, Orens, J, Sonett, J, Wille, K, Crespo, M, Weill, D, Kohl, B, Deutschman, C, Arcasoy, S, Shah, A, Shah, P.D, Demissie, E.J, Reynolds, J, Belperio, J, Wilkes, D, Ware, L, Christie, J.D

Get full text

49 Elevated PTX3 Concentration Is Associated with Primary Graft Dysfunction after Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis by Diamond, J.M, Lederer, D, Kawut, S.M, Lee, J, Cantu, E, Ahya, V, Palmer, S, Weinacker, A, Bhorade, S, Lama, V, Orens, J.B, Sonett, J, Wille, K, Crespo, M, Weill, D, Kohl, B, Deutschman, C, Arcasoy, S, Shah, A, Shah, P.D, Demissie, E.J, Reynolds, J.M, Belperio, J, Wilkes, D, Ware, L, Christie, J.D

Get full text

154: Long Term Follow-Up in the AIRSAC Trial, a Multicenter Randomized Clinical Trial in Lung Transplant Recipients by Bhorade, S.M, Ahya, V, Kotloff, R, Baz, M, Valentine, V, Arcasoy, S, Love, R, deOliveira, A, Bag, R, Seethamraju, H, Alex, C, Vigneswaran, W.T, Charbeneau, J, Krishnan, J, Durazo, R, Garrity, E.R

Get full text

209: Sirolimus Is Associated with an Increase Risk of Venous Thromboembolism in Lung Transplantation by McShane, P.J, Bhorade, S.M, Baz, M, Valentine, V, Arcasoy, S, Love, R, Seethamraju, H, Garrity, E, Alex, C, Bag, R, deOliveira, A, Vigneswaran, W, Charbeneau, J, Krishnan, J, Durazo, R, Ahya, V

Get full text